81 related articles for article (PubMed ID: 1484893)
1. Inhibitory effect of tannic acid sulfate and related sulfates on infectivity, cytopathic effect, and giant cell formation of human immunodeficiency virus.
Mizuno T; Uchino K; Toukairin T; Tanabe A; Nakashima H; Yamamoto N; Ogawara H
Planta Med; 1992 Dec; 58(6):535-9. PubMed ID: 1484893
[TBL] [Abstract][Full Text] [Related]
2. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency viral replication by tannins and related compounds.
Nakashima H; Murakami T; Yamamoto N; Sakagami H; Tanuma S; Hatano T; Yoshida T; Okuda T
Antiviral Res; 1992 May; 18(1):91-103. PubMed ID: 1416904
[TBL] [Abstract][Full Text] [Related]
4. Effects of Catuaba extracts on microbial and HIV infection.
Manabe H; Sakagami H; Ishizone H; Kusano H; Fujimaki M; Wada C; Komatsu N; Nakashima H; Murakami T; Yamamoto N
In Vivo; 1992; 6(2):161-5. PubMed ID: 1525337
[TBL] [Abstract][Full Text] [Related]
5. Gallotannins and related polyphenols from Pistacia weinmannifolia.
Hou AJ; Peng LY; Liu YZ; Lin ZW; Sun HD
Planta Med; 2000 Oct; 66(7):624-6. PubMed ID: 11105566
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the safety of blood products with respect to human immunodeficiency virus infection by using an HTLV-I-infected cell line (SKT-1B).
Koito A; Shirono K; Suto H; Matsushita S; Hattori T; Takatsuki K
Jpn J Cancer Res; 1987 Apr; 78(4):365-71. PubMed ID: 2884206
[TBL] [Abstract][Full Text] [Related]
7. A new anti-human immunodeficiency virus substance, glycyrrhizin sulfate; endowment of glycyrrhizin with reverse transcriptase-inhibitory activity by chemical modification.
Nakashima H; Matsui T; Yoshida O; Isowa Y; Kido Y; Motoki Y; Ito M; Shigeta S; Mori T; Yamamoto N
Jpn J Cancer Res; 1987 Aug; 78(8):767-71. PubMed ID: 2443473
[TBL] [Abstract][Full Text] [Related]
8. New substances against human immunodeficiency virus: sulfated 5'-nucleotidase inhibitory polyphenols.
Toukairin T; Uchino K; Mizuno T; Nakashima H; Yamamoto N; Ogawara H
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):802-4. PubMed ID: 1611696
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone.
Sarin PS; Sun D; Thornton A; Müller WE
J Natl Cancer Inst; 1987 Apr; 78(4):663-6. PubMed ID: 2435942
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
Ito M; Nakashima H; Baba M; Pauwels R; De Clercq E; Shigeta S; Yamamoto N
Antiviral Res; 1987 Mar; 7(3):127-37. PubMed ID: 3475037
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of an inhibitor of human immunodeficiency virus infection.
Hatanaka K; Yoshida T; Uryu T; Yoshida O; Nakashima H; Yamamoto N; Mimura T; Kaneko Y
Jpn J Cancer Res; 1989 Feb; 80(2):95-8. PubMed ID: 2498253
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of AIDS virus replication by acemannan in vitro.
Kahlon JB; Kemp MC; Carpenter RH; McAnalley BH; McDaniel HR; Shannon WM
Mol Biother; 1991 Sep; 3(3):127-35. PubMed ID: 1768365
[TBL] [Abstract][Full Text] [Related]
13. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
Lifson JD; Feinberg MB; Reyes GR; Rabin L; Banapour B; Chakrabarti S; Moss B; Wong-Staal F; Steimer KS; Engleman EG
Nature; 1986 Oct 23-29; 323(6090):725-8. PubMed ID: 3095663
[TBL] [Abstract][Full Text] [Related]
14. Development of new potent and selective agents against HIV (human immunodeficiency virus).
Pauwels R; Schols D
Verh K Acad Geneeskd Belg; 1991; 53(6):629-55. PubMed ID: 1816706
[TBL] [Abstract][Full Text] [Related]
15. Plant polyphenols inhibit benzoyl peroxide-induced superoxide anion radical production and diacylglyceride formation in murine peritoneal macrophages.
Kaul A; Khanduja KL
Nutr Cancer; 1999; 35(2):207-11. PubMed ID: 10693177
[TBL] [Abstract][Full Text] [Related]
16. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
[TBL] [Abstract][Full Text] [Related]
17. Substances affecting the infection and replication of human immunodeficiency virus (HIV).
Yamamoto N; Harada S; Nakashima H
AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346
[TBL] [Abstract][Full Text] [Related]
18. Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities.
Chiba H; Inokoshi J; Okamoto M; Asanuma S; Matsuzaki Ki ; Iwama M; Mizumoto K; Tanaka H; Oheda M; Fujita K; Nakashima H; Shinose M; Takahashi Y; Omura S
Biochem Biophys Res Commun; 2001 Mar; 282(2):595-601. PubMed ID: 11401502
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of the crude extract from a seaweed of Dygenea simplex C. Agardh on the in vitro cytopathic activity of HIV-1 and it's antigen production.
Sekine H; Ohonuki N; Sadamasu K; Monma K; Kudoh Y; Nakamura H; Okada Y; Okuyama T
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1580-4. PubMed ID: 7586085
[TBL] [Abstract][Full Text] [Related]
20. Anti-human immunodeficiency virus type 1 activity of sulfated monosaccharides: comparison with sulfated polysaccharides and other polyions.
Bagasra O; Whittle P; Heins B; Pomerantz RJ
J Infect Dis; 1991 Dec; 164(6):1082-90. PubMed ID: 1720153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
